Gene: VAV2
Official Full Name: vav guanine nucleotide exchange factor 2provided by HGNC
Gene Summary: VAV2 is the second member of the VAV guanine nucleotide exchange factor family of oncogenes. Unlike VAV1, which is expressed exclusively in hematopoietic cells, VAV2 transcripts were found in most tissues. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08673 | VAV2 Knockout cell line (HeLa) | Human | VAV2 | 1:3~1:6 | Negative | Online Inquiry |
KO08674 | VAV2 Knockout cell line (HCT 116) | Human | VAV2 | 1:2~1:4 | Negative | Online Inquiry |
KO08675 | VAV2 Knockout cell line (HEK293) | Human | VAV2 | 1:3~1:6 | Negative | Online Inquiry |
KO08676 | VAV2 Knockout cell line (A549) | Human | VAV2 | 1:3~1:4 | Negative | Online Inquiry |
VAV2 Gene Knockout Cell Lines are genetically modified cell lines specifically designed to exhibit a complete loss of function of the VAV2 gene, a critical regulator in various cellular processes, including signal transduction and cytoskeletal dynamics. By employing CRISPR/Cas9 technology, these cell lines enable researchers to study the specific contributions of VAV2 in cellular signaling pathways and its implications in diseases such as cancer and autoimmune disorders.
The key function of VAV2 is its role as a guanine nucleotide exchange factor (GEF) for Rho family GTPases, which modulates cytoskeletal rearrangements and cellular signaling. In knockout models, researchers can dissect the downstream effects of VAV2 loss, examining alterations in cellular morphology, migration, and proliferation. This knowledge is paramount for understanding the molecular mechanisms underlying pathological conditions and for developing targeted therapeutic strategies.
The scientific importance of VAV2 Gene Knockout Cell Lines extends to both basic and translational research. These models facilitate the exploration of pathogenic mechanisms in cancer progression, immune response regulation, and neurodevelopmental disorders, making them invaluable tools in academic and clinical laboratories. Researchers can leverage these cell lines to evaluate potential drug compounds, biomarker discovery, and pathways that may present therapeutic targets.
One of the specific advantages of VAV2 Gene Knockout Cell Lines compared to traditional gene knockdown techniques is their complete and stable gene disruption. This superior specificity reduces off-target effects and enhances the reliability of experimental outcomes. Additionally, our cell lines come validated with comprehensive characterization data, ensuring high-quality results and reproducibility that are paramount in scientific investigations.
For researchers and clinicians focused on advancing our understanding of cell signaling and disease mechanisms, VAV2 Gene Knockout Cell Lines offer a robust platform for innovative research and experimental design. With our expertise in biotechnology and a commitment to providing high-quality biological products, we empower scientists with the tools necessary for groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.